• Je něco špatně v tomto záznamu ?

The role of VEGF in the diabetic patients undergoing endovascular therapy of symptomatic aortic valve stenosis

V. Bláha, J. Šťásek, J. Bis, J. Fortunato, C. Andrýs, V. Pavlík, P. Polanský, M. Brtko, L. Sobotka

. 2014 ; 63 (Suppl. 3) : S351-S359.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16004146

Grantová podpora
NT12287 MZ0 CEP - Centrální evidence projektů

The aim of this study was to explore changes in plasma vascular endothelial growth factor (VEGF) in aged patients who undergone transcatheter aortic valve implantation or balloon angioplasty for the treatment of aortic stenosis. Plasma VEGF was measured in subjects with diabetes mellitus type 2 (DM) (n=21, age 79.2+/-1.6 years) and in non-diabetic subjects (non-DM) (n=23, age 84.4+/-0.7 years), using an ELISA kit. Before the procedure plasma levels of VEGF were significantly lower in DM than in non-DM patients (P<0.05). Plasma VEGF significantly increased in both groups (DM and non-DM) 24 h (387+/-64 vs. 440+/-30 pg/ml, P<0.05) and 72 h (323+/-69 vs. 489+/-47 pg/ml, P<0.05) after the endovascular procedure. However, the VEGF in DM patients was significantly lower compared to non-DM subjects up to one month after the endovascular procedure (283+/-47 vs. 386+/-38 pg/ml, P<0.05). We conclude that increased plasma VEGF in aged patients associates with atherosclerotic aortic valve stenosis. In spite of that plasma VEGF in DM was constantly significantly lower than in non diabetic patients, both before and after the endovascular procedure, possibly reflecting a disturbance of angiogenic/anti-angiogenic balance in diabetes.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16004146
003      
CZ-PrNML
005      
20190816085838.0
007      
ta
008      
160208s2014 xr f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.932857 $2 doi
035    __
$a (PubMed)25428740
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Bláha, Vladimír, $u Third Department of Internal Medicine, Metabolism and Gerontology, University Hospital Hradec Králové and Medical Faculty Charles University in Hradec Králové, Hradec Králové, Czech Republic $d 1964- $7 xx0002944
245    14
$a The role of VEGF in the diabetic patients undergoing endovascular therapy of symptomatic aortic valve stenosis / $c V. Bláha, J. Šťásek, J. Bis, J. Fortunato, C. Andrýs, V. Pavlík, P. Polanský, M. Brtko, L. Sobotka
520    9_
$a The aim of this study was to explore changes in plasma vascular endothelial growth factor (VEGF) in aged patients who undergone transcatheter aortic valve implantation or balloon angioplasty for the treatment of aortic stenosis. Plasma VEGF was measured in subjects with diabetes mellitus type 2 (DM) (n=21, age 79.2+/-1.6 years) and in non-diabetic subjects (non-DM) (n=23, age 84.4+/-0.7 years), using an ELISA kit. Before the procedure plasma levels of VEGF were significantly lower in DM than in non-DM patients (P<0.05). Plasma VEGF significantly increased in both groups (DM and non-DM) 24 h (387+/-64 vs. 440+/-30 pg/ml, P<0.05) and 72 h (323+/-69 vs. 489+/-47 pg/ml, P<0.05) after the endovascular procedure. However, the VEGF in DM patients was significantly lower compared to non-DM subjects up to one month after the endovascular procedure (283+/-47 vs. 386+/-38 pg/ml, P<0.05). We conclude that increased plasma VEGF in aged patients associates with atherosclerotic aortic valve stenosis. In spite of that plasma VEGF in DM was constantly significantly lower than in non diabetic patients, both before and after the endovascular procedure, possibly reflecting a disturbance of angiogenic/anti-angiogenic balance in diabetes.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a aortální stenóza $x krev $x diagnóza $x chirurgie $7 D001024
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a průřezové studie $7 D003430
650    _2
$a diabetes mellitus 2. typu $x krev $x diagnóza $x chirurgie $7 D003924
650    _2
$a endovaskulární výkony $x trendy $7 D057510
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a pooperační péče $x trendy $7 D011182
650    12
$a transkatetrální implantace aortální chlopně $x trendy $7 D065467
650    _2
$a vaskulární endoteliální růstový faktor A $x krev $7 D042461
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Šťásek, Josef, $d 1955- $7 xx0063485 $u First Department of Internal Medicine – Cardioangiology, University Hospital Hradec Králové and Medical Faculty Charles University in Hradec Králové, Czech Republic
700    1_
$a Bis, Josef $7 xx0071045 $u First Department of Internal Medicine – Cardioangiology, University Hospital Hradec Králové and Medical Faculty Charles University in Hradec Králové, Czech Republic
700    1_
$a Fortunato, Joao $7 xx0227880 $u Third Department of Internal Medicine, Metabolism and Gerontology, University Hospital Hradec Králové and Medical Faculty Charles University in Hradec Králové, Hradec Králové, Czech Republic
700    1_
$a Andrýs, Ctirad, $d 1962- $7 mzk2008430528 $u Department of Immunology and Alergology, University Hospital Hradec Králové and Medical Faculty Charles University in Hradec Králové, Czech Republic
700    1_
$a Pavlík, Viktor $7 xx0128276 $u Third Department of Internal Medicine, Metabolism and Gerontology, University Hospital Hradec Králové and Medical Faculty Charles University in Hradec Králové, Hradec Králové, Czech Republic
700    1_
$a Polanský, Pavel $7 xx0101818 $u Department of Cardiosurgery, University Hospital Hradec Králové and Medical Faculty Charles University in Hradec Králové, Czech Republic
700    1_
$a Brtko, Miroslav $7 xx0035884 $u Department of Cardiosurgery, University Hospital Hradec Králové and Medical Faculty Charles University in Hradec Králové, Czech Republic
700    1_
$a Sobotka, Luboš, $d 1952- $7 jn20001005317 $u Third Department of Internal Medicine, Metabolism and Gerontology, University Hospital Hradec Králové and Medical Faculty Charles University in Hradec Králové, Hradec Králové, Czech Republic
773    0_
$w MED00003824 $t Physiological research Academia Scientiarum Bohemoslovaca $x 1802-9973 $g Roč. 63, Suppl. 3 (2014), s. S351-S359
773    0_
$t Supplement on the occasion of the 18th annual congress on atherosclerosis $g (2014), s. S351-S359 $w MED00190347
856    41
$u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20160208 $b ABA008
991    __
$a 20190816090108 $b ABA008
999    __
$a ok $b bmc $g 1107752 $s 928414
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 63 $c Suppl. 3 $d S351-S359 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
BMC    ##
$a 2014 $d S351-S359 $m Supplement on the occasion of the 18th annual congress on atherosclerosis $x MED00190347
GRA    __
$a NT12287 $p MZ0
LZP    __
$b NLK118 $a Pubmed-20160208

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...